Used in research and development for Alzheimer's disease, particularly targeting amyloid-beta plaques in the brain. It serves as a reference tool in immunoassays to measure amyloid-beta levels and evaluate the efficacy of therapeutic antibodies. Commonly applied in preclinical studies to standardize detection methods and support the validation of diagnostic imaging agents. Also utilized in comparative studies to assess binding characteristics and functional activity of new anti-amyloid antibodies.